|
1
|
Lehmann MH, Torres-Domínguez LE, Price PJ,
Brandmüller C, Kirschning CJ and Sutter G: CCL2 expression is
mediated by type I IFN receptor and recruits NK and T cells to the
lung during MVA infection. J Leukoc Biol. 99:1057–1064. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qidwai T: Chemokine genetic polymorphism
in human health and disease. Immunol Lett. 176:128–138. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim MS, Day CJ and Morrison NA: MCP-1 is
induced by receptor activator of nuclear factor-{kappa}B ligand,
promotes human osteoclast fusion, and rescues granulocyte
macrophage colony-stimulating factor suppression of osteoclast
formation. J Biol Chem. 280:16163–16169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim MS, Day CJ, Selinger CI, Magno CL,
Stephens SR and Morrison NA: MCP-1-induced human osteoclast-like
cells are tartrate-resistant acid phosphatase, NFATc1, and
calcitonin receptor-positive but require receptor activator of
NFkappaB ligand for bone resorption. J Biol Chem. 281:1274–1285.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morrison NA, Day CJ and Nicholson GC:
Dominant negative MCP-1 blocks human osteoclast differentiation. J
Cell Biochem. 115:303–312. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Quan J, Johnson NW, Zhou G, Parsons PG,
Boyle GM and Gao J: Potential molecular targets for inhibiting bone
invasion by oral squamous cell carcinoma: A review of mechanisms.
Cancer Metastasis Rev. 31:209–219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quan J, Elhousiny M, Johnson NW and Gao J:
Transforming growth factor-β1 treatment of oral cancer induces
epithelial-mesenchymal transition and promotes bone invasion via
enhanced activity of osteoclasts. Clin Exp Metastasis. 30:659–670.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Quan J, Morrison NA, Johnson NW and Gao J:
MCP-1 as a potential target to inhibit the bone invasion by oral
squamous cell carcinoma. J Cell Biochem. 115:1787–1798. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gu J, Feng Y, Feng X, Sun C, Lei L, Ding
W, Niu F, Jiao L, Yang M, Li Y, et al: Structural and biochemical
characterization reveals LysGH15 as an unprecedented ‘EF-hand-like’
calcium-binding phage lysine. PLoS Pathog. 10:e10041092014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gong QM, Quan JJ, Jiang HW and Ling JQ:
Regulation of the stromal cell-derived factor-1alpha-CXCR4 axis in
human dental pulp cells. J Endod. 36:1499–1503. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Ernst CA and Rollins BJ: MCP-1:
Structure/activity analysis. Methods. 10:93–103. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y and Rollins BJ: A dominant
negative inhibitor indicates that monocyte chemoattractant protein
1 functions as a dimer. Mol Cell Biol. 15:4851–4855. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ikeda Y, Yonemitsu Y, Kataoka C, Kitamoto
S, Yamaoka T, Nishida K, Takeshita A, Egashira K and Sueishi K:
Anti-monocyte chemoattractant protein-1 gene therapy attenuates
pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol.
283:H2021–H2028. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ni W, Egashira K, Kitamoto S, Kataoka C,
Koyanagi M, Inoue S, Imaizumi K, Akiyama C, Nishida KI and
Takeshita A: New anti-monocyte chemoattractant protein-1 gene
therapy attenuates atherosclerosis in apolipoprotein E-knockout
mice. Circulation. 103:2096–2101. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koga M, Kai H, Egami K, Murohara T, Ikeda
A, Yasuoka S, Egashira K, Matsuishi T, Kai M, Kataoka Y, et al:
Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of
malignant melanoma in mice. Biochem Biophys Res Commun.
365:279–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yao Z, Keeney M, Lin TH, Pajarinen J,
Barcay K, Waters H, Egashira K, Yang F and Goodman S: Mutant
monocyte chemoattractant protein 1 protein attenuates migration of
and inflammatory cytokine release by macrophages exposed to
orthopedic implant wear particles. J Biomed Mater Res A.
102:3291–3297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang X, Sato T, Yao Z, Keeney M,
Pajarinen J, Lin TH, Loi F, Egashira K, Goodman S and Yang F: Local
delivery of mutant CCL2 protein-reduced orthopaedic implant wear
particle-induced osteolysis and inflammation in vivo. J Orthop Res.
34:58–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Keeney M, Waters H, Barcay K, Jiang X, Yao
Z, Pajarinen J, Egashira K, Goodman SB and Yang F: Mutant MCP-1
protein delivery from layer-by-layer coatings on orthopedic
implants to modulate inflammatory response. Biomaterials.
34:10287–10295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nabeshima A, Pajarinen J, Lin TH, Jiang X,
Gibon E, Córdova LA, Loi F, Lu L, Jämsen E, Egashira K, et al:
Mutant CCL2 protein coating mitigates wear particle-induced bone
loss in a murine continuous polyethylene infusion model.
Biomaterials. 117:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Severin IC, Souza AL, Davis JH, Musolino
N, Mack M, Power CA and Proudfoot AE: Properties of 7ND-CCL2 are
modulated upon fusion to Fc. Protein Eng Des Sel. 25:213–222. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Russmueller G, Moser D, Würger T, Wrba F,
Christopoulos P, Kostakis G, Seemann R, Stadler V, Wimmer G, Kornek
G, et al: Upregulation of osteoprotegerin expression correlates
with bone invasion and predicts poor clinical outcome in oral
cancer. Oral Oncol. 51:247–253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tada Y, Kokabu S, Sugiyama G, Nakatomi C,
Aoki K, Fukushima H, Osawa K, Sugamori Y, Ohya K, Okamoto M, et al:
The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by
oral squamous cellcarcinoma. Oncotarget. 5:12317–12330. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hsu FT, Chang B, Chen JC, Chiang IT, Liu
YC, Kwang WK and Hwang JJ: Synergistic effect of sorafenib and
radiation on human oral carcinoma in vivo. Sci Rep. 5:153912015.
View Article : Google Scholar : PubMed/NCBI
|
